JIA Xuan, PAN Guohairong, TIAN Yuan, WANG Hanli, LIANG Qun. Research progress on role of intestinal microbiota in sepsis[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 125-129, 143. DOI: 10.7619/jcmp.20220816
Citation: JIA Xuan, PAN Guohairong, TIAN Yuan, WANG Hanli, LIANG Qun. Research progress on role of intestinal microbiota in sepsis[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 125-129, 143. DOI: 10.7619/jcmp.20220816

Research progress on role of intestinal microbiota in sepsis

More Information
  • Received Date: March 14, 2022
  • Available Online: July 13, 2022
  • Intestinal microbiota is mainly involved in idiopathic acute inflammation such as inflammatory bowel disease, ulcerative colitis and Crohn's disease. Studies in recent years have found that intestinal microbiota can affect the occurrence, development and prognosis of sepsis. This article reviewed the mechanism of intestinal microbiota in sepsis, and provided new therapeutic concepts and means for sepsis.

  • [1]
    FONT M D, THYAGARAJAN B, KHANNA A K. Sepsis and Septic Shock-Basics of diagnosis, pathophysiology and clinical decision making[J]. Med Clin North Am, 2020, 104(4): 573-585. doi: 10.1016/j.mcna.2020.02.011
    [2]
    HEMING N, AZABOU E, CAZAUMAYOU X, et al. Sepsis in the critically ill patient: current and emerging management strategies[J]. Expert Rev Anti Infect Ther, 2021, 19(5): 635-647. doi: 10.1080/14787210.2021.1846522
    [3]
    张冬静, 翟哲, 高岩. 外泌体在脓毒症器官功能障碍中的研究进展[J]. 实用临床医药杂志, 2021, 25(14): 113-117, 122. doi: 10.7619/jcmp.20211209
    [4]
    ODENWALD M A, TURNER J R. The intestinal epithelial barrier: a therapeutic target[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(1): 9-21. doi: 10.1038/nrgastro.2016.169
    [5]
    YOKOYAMA H, SEKINO M, FUNAOKA H, et al. Association between enterocyte injury and fluid balance in patients with septic shock: a post hoc exploratory analysis of a prospective observational study[J]. BMC Anesthesiol, 2021, 21(1): 293. doi: 10.1186/s12871-021-01515-2
    [6]
    ZHOU X, LIAO Y X. Gut-lung crosstalk in Sepsis-induced acute lung injury[J]. Front Microbiol, 2021, 12: 779620. doi: 10.3389/fmicb.2021.779620
    [7]
    SINGER J R, BLOSSER E G, ZINDL C L, et al. Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset Sepsis[J]. Nat Med, 2019, 25(11): 1772-1782. doi: 10.1038/s41591-019-0640-y
    [8]
    KHAN I, BAI Y R, ZHA L J, et al. Mechanism of the gut microbiota colonization resistance and enteric pathogen infection[J]. Front Cell Infect Microbiol, 2021, 11: 716299. doi: 10.3389/fcimb.2021.716299
    [9]
    MORROW L E, GOGINENI V, MALESKER M A. Probiotics in the intensive care unit[J]. Nutr Clin Pract, 2012, 27(2): 235-241. doi: 10.1177/0884533612440290
    [10]
    刘委宏, 郝浩, 刘阳, 等. 半夏泻心汤通过调控HO-1的表达改善脓毒症大鼠肠道损伤的机制研究[J]. 中国中医急症, 2021, 30(6): 945-949. doi: 10.3969/j.issn.1004-745X.2021.06.002
    [11]
    ZHOU A, YUAN Y, YANG M, et al. Crosstalk between the gut microbiota and epithelial cells under physiological and infectious conditions[J]. Front Cell Infect Microbiol, 2022, 12: 832672. doi: 10.3389/fcimb.2022.832672
    [12]
    LV L X, PENG L, SHI D, et al. Probiotic combination CBLEB alleviates Streptococcus pneumoniae infection through immune regulation in immunocompromised rats[J]. J Inflamm Res, 2022, 15: 987-1004. doi: 10.2147/JIR.S348047
    [13]
    MARTIN-GALLAUSIAUX C, MARINELLI L, BLOTTIōRE H M, et al. SCFA: mechanisms and functional importance in the gut[J]. Proc Nutr Soc, 2021, 80(1): 37-49. doi: 10.1017/S0029665120006916
    [14]
    ZHENG Z Z, DENG W Y, BAI Y, et al. The lysosomal rag-ragulator complex licenses RIPK1 and caspase-8-mediated pyroptosis by Yersinia[J]. Science, 2021, 372(6549): eabg0269. doi: 10.1126/science.abg0269
    [15]
    伍婷, 徐方明, 苏丛, 等. 晚期内含子/溶酶体适配子和促分裂原活化蛋白激酶以及哺乳动物重组雷帕霉素激活物分子2基因的RNA干扰慢病毒载体的构建及其对巨噬细胞中炎性因子分泌的影响[J]. 中华传染病杂志, 2019, 37(10): 605-609. doi: 10.3760/cma.j.issn.1000-6680.2019.10.006
    [16]
    SCHULTHESS J, PANDEY S, CAPITANI M, et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages[J]. Immunity, 2019, 50(2): 432-445, e7. doi: 10.1016/j.immuni.2018.12.018
    [17]
    ADELMAN M W, WOODWORTH M H, LANGELIER C, et al. The gut microbiome's role in the development, maintenance, and outcomes of Sepsis[J]. Crit Care, 2020, 24(1): 278. doi: 10.1186/s13054-020-02989-1
    [18]
    陈嘉琪, 钱义明, 钱风华, 等. 基于脑肠肽探讨针刺治疗急性胃肠损伤的作用机制[J]. 实用临床医药杂志, 2021, 25(18): 120-123. doi: 10.7619/jcmp.20211167
    [19]
    THIRIET C, MAHJOUB K, COURTE G, et al. Automated measurement of neutrophil CD64 expression for diagnosing Sepsis in critically ill patients[J]. Minerva Anestesiol, 2019, 85(9): 943-950.
    [20]
    ASSIMAKOPOULOS S F, TRIANTOS C, THOMOPOULOS K, et al. Gut-origin Sepsis in the critically ill patient: pathophysiology and treatment[J]. Infection, 2018, 46(6): 751-760. doi: 10.1007/s15010-018-1178-5
    [21]
    戴盈, 秦少云, 潘华琴, 等. 急性生理评分与序贯器官衰竭评估评分预测高龄脓毒症患者预后的价值[J]. 实用临床医药杂志, 2019, 23(4): 37-40. doi: 10.7619/jcmp.201904011
    [22]
    CHENG C, YU X. Research progress in Chinese herbal medicines for treatment of Sepsis: pharmacological action, phytochemistry, and pharmacokinetics[J]. Int J Mol Sci, 2021, 22(20): 11078. doi: 10.3390/ijms222011078
    [23]
    MANRIQUE-CABALLERO C L, DEL RIO-PERTUZ G, GOMEZ H. Sepsis-associated acute kidney injury[J]. Crit Care Clin, 2021, 37(2): 279-301. doi: 10.1016/j.ccc.2020.11.010
    [24]
    SUN J, ZHANG J X, WANG X F, et al. Gut-liver crosstalk in Sepsis-induced liver injury[J]. Crit Care, 2020, 24(1): 614. doi: 10.1186/s13054-020-03327-1
    [25]
    DENG F, ZHAO B C, YANG X, et al. The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis[J]. Gut Microbes, 2021, 13(1): 1-21.
    [26]
    SJAASTAD F V, CONDOTTA S A, KOTOV J A, et al. Polymicrobial Sepsis chronic immunoparalysis is defined by diminished Ag-specific T cell-dependent B cell responses[J]. Front Immunol, 2018, 9: 2532. doi: 10.3389/fimmu.2018.02532
    [27]
    刘方燕, 付湘云, 罗涛, 等. 细胞自噬在脓毒症脑损伤中作用的研究进展[J]. 河北医学, 2022, 28(4): 702-704. doi: 10.3969/j.issn.1006-6233.2022.04.035
    [28]
    WILMORE J R, GAUDETTE B T, GOMEZ ATRIA D, et al. Commensal microbes induce serum IgA responses that protect against polymicrobial Sepsis[J]. Cell Host Microbe, 2018, 23(3): 302-311, e3. doi: 10.1016/j.chom.2018.01.005
    [29]
    PORTINCASA P, BONFRATE L, VACCA M, et al. Gut microbiota and short chain fatty acids: implications in glucose homeostasis[J]. Int J Mol Sci, 2022, 23(3): 1105. doi: 10.3390/ijms23031105
    [30]
    GOMAA E Z. Human gut microbiota/microbiome in health and diseases: a review[J]. Antonie Van Leeuwenhoek, 2020, 113(12): 2019-2040. doi: 10.1007/s10482-020-01474-7
    [31]
    PATANGIA D V, ANTHONY RYAN C, DEMPSEY E, et al. Impact of antibiotics on the human microbiome and consequences for host health[J]. MicrobiologyOpen, 2022, 11(1): e1260.
    [32]
    PARADA VENEGAS D, DE LA FUENTE M K, LANDSKRON G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases[J]. Front Immunol, 2019, 10: 277. doi: 10.3389/fimmu.2019.00277
    [33]
    ZHAO Y, CHEN F D, WU W, et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3[J]. Mucosal Immunol, 2018, 11(3): 752-762. doi: 10.1038/mi.2017.118
    [34]
    ABU Y A, VITARI N, YAN Y, et al. Opioids and Sepsis: elucidating the role of the microbiome and microRNA-146[J]. Int J Mol Sci, 2022, 23(3): 1097. doi: 10.3390/ijms23031097
    [35]
    LUU M, PAUTZ S, KOHL V, et al. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes[J]. Nat Commun, 2019, 10(1): 760. doi: 10.1038/s41467-019-08711-2
    [36]
    WAN Y D, ZHU R X, WU Z Q, et al. Gut microbiota disruption in septic shock patients: a pilot study[J]. Med Sci Monit, 2018, 24: 8639-8646. doi: 10.12659/MSM.911768
    [37]
    RAVI A, HALSTEAD F D, BAMFORD A, et al. Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients[J]. Microb Genom, 2019, 5(9): e000293.
    [38]
    张悦, 王玉莹, 罗海燕, 等. 肠道菌群与脓毒症相互关系的研究进展[J]. 世界华人消化杂志, 2022, 30(2): 109-113. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB202202007.htm
    [39]
    GHANI R, MULLISH B H, ROBERTS L A, et al. The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases[J]. Gut Microbes, 2022, 14(1): 2038856. doi: 10.1080/19490976.2022.2038856
    [40]
    ISSA ISAAC N, PHILIPPE D, NICHOLAS A, et al. Metaproteomics of the human gut microbiota: challenges and contributions to other OMICS[J]. Clin Mass Spectrom, 2019, 14 Pt A: 18-30.
    [41]
    NIU M W, CHEN P. Crosstalk between gut microbiota and Sepsis[J]. Burns Trauma, 2021, 9: tkab036. doi: 10.1093/burnst/tkab036
    [42]
    DÍAZ-DÍAZ L M, RODRÍGUEZ-VILLAFAÍE A, GARCÑA-ARRARÁS J E. The role of the microbiota in regeneration-associated processes[J]. Front Cell Dev Biol, 2022, 9: 768783.
    [43]
    KAZAKOVA S V, BAGGS J, MCDONALD L C, et al. Association between antibiotic use and hospital-onset Clostridioides difficile infection in US acute care hospitals, 2006-2012: an ecologic analysis[J]. Clin Infect Dis, 2020, 70(1): 11-18. doi: 10.1093/cid/ciz169
    [44]
    BARSUK A L, NEKAEVA E S, LOVTSOVA L V, et al. Selective intestinal decontamination as a method for preventing infectious complications (review)[J]. Sovrem Tekhnologii Med, 2021, 12(6): 86-95.
    [45]
    VANDENPLAS Y, CARNIELLI V P, KSIAZYK J, et al. Factors affecting early-life intestinal microbiota development[J]. Nutrition, 2020, 78: 110812.
    [46]
    SUEZ J, ZMORA N, SEGAL E, et al. The pros, cons, and many unknowns of probiotics[J]. Nat Med, 2019, 25(5): 716-729.
    [47]
    DI RENZO L, FRANZA L, MONSIGNORE D, et al. Vaccines, microbiota and immunonutrition: food for thought[J]. Vaccines, 2022, 10(2): 294.
    [48]
    ESLAMI M, SADRIFAR S, KARBALAEI M, et al. Importance of the microbiota inhibitory mechanism on the Warburg effect in colorectal cancer cells[J]. J Gastrointest Cancer, 2020, 51(3): 738-747.
    [49]
    HAAK B W, PRESCOTT H C, WIERSINGA W J. Therapeutic potential of the gut microbiota in the prevention and treatment of Sepsis[J]. Front Immunol, 2018, 9: 2042.
    [50]
    KIM S M, DEFAZIO J R, HYOJU S K, et al. Fecal microbiota transplant rescues mice from human pathogen mediated Sepsis by restoring systemic immunity[J]. Nat Commun, 2020, 11(1): 2354.
  • Related Articles

    [1]HUANG Haifen, CHEN Qingyong, HE Fang, LI Ren. Therapeutic effect and mechanism of individualized treatment for hypertension patients with coronary heart disease under non-invasive cardiac output measurement[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 70-75, 81. DOI: 10.7619/jcmp.20243797
    [2]REN Liping, JIN Wanling, GUO Yuanqing, CAI Beijun. Effect of low-dose aspirin in prevention of adverse pregnancy outcomes in high-risk pregnant women with hypertensive disorders during pregnancy[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 90-92. DOI: 10.7619/jcmp.202015025
    [3]FAN Li, LI Ya′e. Effect of postpartum pelvic floor rehabilitation trainingcombined with pelvic floor rehabilitation instrument on prevention of urinary retention in puerperas[J]. Journal of Clinical Medicine in Practice, 2019, 23(23): 123-125. DOI: 10.7619/jcmp.201923038
    [4]GUAN Lei, LI Na, LI Yanjun. Preventive nursing for patients with contrast-enhanced CT scan[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 121-124. DOI: 10.7619/jcmp.201914033
    [5]YANG Dan. Effect of preventive nursing intervention on incidenceof postoperative infection and satisfaction in elderly patients with hypertensive intracerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 115-118. DOI: 10.7619/jcmp.201912034
    [6]HU Lanping, LIANG Yanmei. Application of root cause analysis in prevention of adverse events in hematodialysis center[J]. Journal of Clinical Medicine in Practice, 2017, (18): 30-32. DOI: 10.7619/jcmp.201718010
    [7]LI Xiaohua, WANG Kun. Nursing effects of adverse nursing for unstable angina pectoris elderly patients with coronary heart disease and prevention of adverse events[J]. Journal of Clinical Medicine in Practice, 2017, (12): 5-7,11. DOI: 10.7619/jcmp.201712002
    [8]LIU Xujiang, CAI Xiaoli, XU Shuya. Effect of sufentanil on preventing early pain afteRanesthesia surgery[J]. Journal of Clinical Medicine in Practice, 2017, (9): 109-112. DOI: 10.7619/jcmp.201709028
    [9]ZHAO Jihong. Role of nursing intervention in prevention of adverse events in patients with intravenous injection of amiodarone[J]. Journal of Clinical Medicine in Practice, 2013, (18): 67-69. DOI: 10.7619/jcmp.201318029
    [10]XIANG Ni. Effect of preventive nursing on treatment of patients with emergency transfusion[J]. Journal of Clinical Medicine in Practice, 2013, (18): 49-51. DOI: 10.7619/jcmp.201318022

Catalog

    Article views (276) PDF downloads (35) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return